Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunquan Sheng

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Acta Pharmaceutica Sinica. B|October 6, 2025
Chemical and genetic molecular glues to degrade CoREST corepressorsYing-Qi Song, Qingjun Li, Chunquan Sheng
Acta Pharmaceutica Sinica. B|November 11, 2024
RMC-7977, a highly selective inhibitor of the active RAS-GTP to treat pancreatic cancerYing-Qi Song, Qingjun Li, Chunquan Sheng
Journal of Medicinal Chemistry|August 2, 2022
Nucleic-Acid-Based Targeted Degradation in Drug DiscoveryWei Wang, Shipeng He, Guoqiang Dong, et al.
Bioorganic Chemistry|June 6, 2022
Efficient synthesis of artificial pharmaceutical solid-phase modules for constructing aptamer-drug conjugatesFei Gao, Hongli Huang, Chunquan Sheng, et al.
Journal of Medicinal Chemistry|July 28, 2021
Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational DiscoveryGuoqiang Dong, Yu Ding, Shipeng He, et al.
Chembiochem : a European Journal of Chemical Biology|October 4, 2024
Precise Modulation of Protein Degradation by Smart PROTACsJunfei Cheng, Guoqiang Dong, Wei Wang, et al.
Current Medicinal Chemistry|February 19, 2014
Updated research and applications of small molecule inhibitors of Keap1-Nrf2 protein-protein interaction: a reviewChunlin Zhuang, Zhenyuan Miao, Chunquan Sheng, et al.
Journal of Medicinal Chemistry|October 28, 2022
Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein DegradationDonghuan Sun, Jing Zhang, Guoqiang Dong, et al.
Acta Pharmaceutica Sinica. B|September 3, 2020
Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activityYahui Huang, Shuqiang Chen, Shanchao Wu, et al.
European Journal of Medicinal Chemistry|November 6, 2021
Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicansChaochen Li, Jie Tu, Guiyan Han, et al.
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Acta Pharmaceutica Sinica. B|October 6, 2025
Chemical and genetic molecular glues to degrade CoREST corepressorsYing-Qi Song, Qingjun Li, Chunquan Sheng
Acta Pharmaceutica Sinica. B|November 11, 2024
RMC-7977, a highly selective inhibitor of the active RAS-GTP to treat pancreatic cancerYing-Qi Song, Qingjun Li, Chunquan Sheng
Journal of Medicinal Chemistry|August 2, 2022
Nucleic-Acid-Based Targeted Degradation in Drug DiscoveryWei Wang, Shipeng He, Guoqiang Dong, et al.
Bioorganic Chemistry|June 6, 2022
Efficient synthesis of artificial pharmaceutical solid-phase modules for constructing aptamer-drug conjugatesFei Gao, Hongli Huang, Chunquan Sheng, et al.
Journal of Medicinal Chemistry|July 28, 2021
Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational DiscoveryGuoqiang Dong, Yu Ding, Shipeng He, et al.
Chembiochem : a European Journal of Chemical Biology|October 4, 2024
Precise Modulation of Protein Degradation by Smart PROTACsJunfei Cheng, Guoqiang Dong, Wei Wang, et al.
Current Medicinal Chemistry|February 19, 2014
Updated research and applications of small molecule inhibitors of Keap1-Nrf2 protein-protein interaction: a reviewChunlin Zhuang, Zhenyuan Miao, Chunquan Sheng, et al.
Journal of Medicinal Chemistry|October 28, 2022
Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein DegradationDonghuan Sun, Jing Zhang, Guoqiang Dong, et al.
Acta Pharmaceutica Sinica. B|September 3, 2020
Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activityYahui Huang, Shuqiang Chen, Shanchao Wu, et al.
European Journal of Medicinal Chemistry|November 6, 2021
Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicansChaochen Li, Jie Tu, Guiyan Han, et al.
Pageof 24